Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis faces shareholder criticism over drug prices at AGM
Yahoo/Reuters
Thu, 02/28/19 - 09:53 am
Tags:
Novartis, drug pricing, shareholders
Novartis first partner in RWE collaboration for dermatology
BioCentury
Wed, 02/27/19 - 07:44 pm
Tags:
Novartis, PharmaSolutions, real world evidence, dermatology
For Novartis, the Michael Cohen affair just won’t stay dead
Stat
Wed, 02/27/19 - 07:13 pm
Tags:
Novartis, Donald Trump, Michael Cohen
Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Cardiovascular Disease Treatments
CP Wire
Wed, 02/27/19 - 10:52 am
Tags:
Blackstone Life Sciences, Anthos Therapeutics, Novartis, MAA868, thromboembolism
Wed, 02/27/19 - 10:14 am
Tags:
Blackstone Life Sciences, Anthos Therapeutics, Novartis, MAA868, thromboembolism
Novartis socked with $1.5M whistleblower verdict
NJ Biz
Tue, 02/26/19 - 06:15 pm
Tags:
Novartis, whistleblower lawsuits, Afinitor, kickbacks
Novartis aims to pump up cardio business with Ionis deal
Yahoo/Reuters
Mon, 02/25/19 - 09:51 am
Tags:
Novartis, Ionis Pharmaceuticals, TQJ230
ICER's life year calculation gives Novartis wider pricing ballpark for SMA therapy
BioCentury
Sat, 02/23/19 - 04:36 pm
Tags:
Novartis, Zolgensma, AVXS-101, spinal muscular atrophy, ICER
Novartis’ AveXis doubles down with $115M manufacturing investment
Fierce Pharma
Tue, 02/19/19 - 12:16 pm
Tags:
Novartis, AveXix, North Carolina, hirings, drug manufacturing
Novartis Positioned to Be World's Top Drug Seller in 2024
Yahoo/Guru Focus
Tue, 02/19/19 - 09:50 am
Tags:
Novartis
NICE provides first scientific advice on patient preference
BioCentury
Sat, 02/16/19 - 04:32 pm
Tags:
NICE, COPD, Novartis, clinical trials`
Medicare would cover CAR-T cell therapies under new CMS proposal
Marketwatch
Fri, 02/15/19 - 12:22 pm
Tags:
Medicare, CAR-T, cell therapy, CMS, Novartis, Kymriah, Gilead Sciences, Yescarta
Novartis secures regulatory 'fast pass' in US OK for tropical disease drug
Biopharma Dive
Thu, 02/14/19 - 05:43 pm
Tags:
Novartis, FDA, Egaten, fast pass, priority review
Novartis inks 10-target antibody discovery deal with AbCellera
Fierce Biotech
Thu, 02/14/19 - 09:45 am
Tags:
Novartis, R&D, antibodies, AbCellera
Pharma Novartis chief’s 2018 take-home pay suffers—not from Cohen but from low-grade returns
Fierce Pharma
Wed, 02/13/19 - 11:49 am
Tags:
Pharma CEOs, Novartis, executive pay, Vas Narasimhan
Clinigen Group Acquires U.S. Rights to Proleukin from Novartis
BioSpace
Wed, 02/13/19 - 10:14 am
Tags:
Novartis, Clinigen, Proleukin, metastatic renal cell carcinoma
Novartis CEO lauds Trump administration plan to overhaul rebates
Yahoo/Reuters
Thu, 02/7/19 - 09:40 am
Tags:
Novartis, Vas Narasimhan, Pharma CEOs, drug pricing, Donald Trump, drug rebates
Novartis spend on digital and data ‘in the 100s of millions’
Pharma Times
Sat, 02/2/19 - 12:43 pm
Tags:
Novartis, digital health, clinical trial data
Mark Your Calendar For These February PDUFA Dates
Yahoo/Benzinga
Sat, 02/2/19 - 12:31 pm
Tags:
FDA, DWP-450, Evolus, MOTIF BIO PLC/S ADR, Iclaprim, Bausch Health, Duobrii, Merck, Keytruda, Incyte, Novartis, ruxolitinib, Novo Nordisk, N8-GP
Oncology round-up: CAR-T conference raises hopes for solid tumour therapy
Pharmaforum
Fri, 02/1/19 - 10:44 pm
Tags:
CAR-T, CAR-T Congress, oncology, Novartis, Kymriah, Europe

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.